Article
MiR-34a deficiency accelerates medulloblastoma formation in vivo.
International journal of cancer - 15 May 2015
Thor Theresa, Künkele Annette, Pajtler Kristian W, Wefers Annika K, Stephan Harald, Mestdagh Pieter, Heukamp Lukas, Hartmann Wolfgang, Vandesompele Jo, Sadowski Natalie, Becker Lore, Garrett Lillian, Hölter Sabine M, Horsch Marion, Calzada-Wack Julia, Klein-Rodewald Tanja, Racz Ildiko, Zimmer Andreas, Beckers Johannes, Neff Frauke, Klopstock Thomas, De Antonellis Pasqualino, Zollo Massimo, Wurst Wolfgang, Fuchs Helmut, Gailus-Durner Valérie, Schüller Ulrich, de Angelis Martin Hrabě, Eggert Angelika, Schramm Alexander, Schulte Johannes H
Abstract excerpt
Previous studies have evaluated the role of miRNAs in cancer initiation and progression. MiR-34a was found to be downregulated in several tumors, including medulloblastomas. Here we employed targeted transgenesis to analyze the function of miR-34a in vivo. We generated mice with a constitutive deletion of the miR-34a gene. These mice were devoid of mir-34a expression in all analyzed tissues, but were viable and...
Topics
- Animals
- Cell Line, Tumor
- Cell Proliferation
- Cerebellar Neoplasms
- Cerebellum
- Gene Expression Regulation, Neoplastic
- Gene Knockout Techniques
